1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06-2247, NCT00442533
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 130046, 13-C-0046, NCT01766635
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 1 Sponsor: NCI, Other Protocol IDs: 04-148, MSKCC-04148, NCT00107289
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 78,256, NCT01237457
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 23811, NCT01635907
|
|
6.
|
Phase: Phase I Type: Treatment Status: Active Age: 2 to 25 Sponsor: NCI, Other Protocol IDs: CDR0000257582, UIHC-200008086, NCI-V02-1710, 200008086, NCT00049023
|